✦ LIBER ✦

Thromboprophylaxis with low-molecular-weight heparin in medical patients with cancer

✍ Scribed by Gary H. Lyman

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 312 KB
Volume: 115
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.24665

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Unfractionated- versus low-molecular-wei

Unfractionated- versus low-molecular-weight-heparin-associated HIT in hospitalized medical patients

✍ Gilles L. Fraser; Richard R. Riker 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB

I n the pharmacoeconomic evaluation of enoxaparin versus un- fractionated heparin (UFH) for the prevention of venous thrombosis in medical patients, Leykum et al. 1 concluded that lowmolecular-weight heparin (LMWH) offered greater cost utility. This important benefit was based on a single advantage

Low molecular weight heparin compared wi

Low molecular weight heparin compared with unfractionated heparin in prevention of postoperative thrombosis

✍ M. Samama Professor; P. Bernard; J. P. Bonnardot; Sophie Combe-Tamzali; Y. Lanso 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB

Low-molecular-weight Heparin for the tre

Low-molecular-weight Heparin for the treatment of venous thrombosis in patients with adenocarcinoma

✍ Eikelboom, John W.; Baker, Ross I. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB 👁 2 views

This case further supports

Thrombosis prophylaxis with low molecula

Thrombosis prophylaxis with low molecular weight heparin in total hip replacement

✍ Dr B. I. Eriksson; B. E. Zachrisson; A.-C. Teger-Nilsson; B. Risberg 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 619 KB

Low molecular weight heparin stimulates

Low molecular weight heparin stimulates megakaryocytopoiesis in bone-marrow transplantation patients

✍ Or, Reuven; Elad, Sharon; Shpilberg, Ofer; Eldor, Amiram 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 2 views

The use of low molecular weight heparin (LMWH) as prophylaxis for veno-occlusive disease of the liver has been studied in patients undergoing bone marrow transplantation (BMT). The present study analyzes the effect of LMWH on the time course of platelet recovery after BMT. Significantly accelerated

Generation of antibodies to heparin-PF4

Generation of antibodies to heparin-PF4 complexes without thrombocytopenia in patients treated with unfractionated or low-molecular-weight heparin

✍ Amiral, Jean; Peynaud-Debayle, Edith; Wolf, Martine; Bridey, Françoise; Vissac, 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 695 KB

The incidence of antibodies to heparin-PF4 complexes (H-PF4) has been evaluated in patients who were under heparin therapy for more than 7 days: 109 patients treated with unfractionated heparin (UH) and 100 patients with low-molecular-weight heparin (LMWH). The presence of antibodies was identified